[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 21, 1993

Screening for Gestational Diabetes-Reply

Author Affiliations

University of Washington Seattle

JAMA. 1993;270(3):324. doi:10.1001/jama.1993.03510030048030
Abstract

In Reply.  —Dr Ring asks about perinatal morbidity in pregnancies with one rather than the usual two abnormal GTT values that are diagnostic for GDM. Previous studies show that a single GTT abnormality by NDDG criteria is associated with increased perinatal morbidity.1,2 To investigate this question in our own data set, we first determined if individuals with one abnormal value by the NDDG criteria had increased perinatal morbidity. We previously found that 65 (3.2%) of the women screened had two elevated GTT values by NDDG criteria, the classical definition of GDM. An additional 60 women (3.0%) of those screened had one elevated GTT value by NDDG criteria. The macrosomia rate (birth weight, >4000 g) was 29% in the GDM group and 25% in the group with one abnormal value, consistent with previous reports.1,2 We then determined how many of the 60 individuals with one elevated NDDG value had

×